SLC38A2 and melanoma: As MeAIB does not just selectively inhibit SNAT1/SLC38A1, but also SNAT2/SLC38A2 and SNAT4/SLC38A4, we further analyzed specific SNAT1 effects using an siPool for selective downregulation of SNAT1 mRNA in melanoma cells.